Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB
Clinical trial NCT03470233 · COMPLETED
Trial details
- NCT number
- NCT03470233
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-05-25
- Primary completion
- 2021-06-21
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.